The Academy of Pharmaceutical Sciences

US broker round-up

Top US stock recommendations of the day: ADVANCED MICRO DEVICES: Jefferies & Co reiterates BUY rating.

McKesson Co. Announces Quarterly Dividend of $0.22

McKesson declared a quarterly dividend on Wednesday, May 22nd, AnalystRatingsNetwork reports.

Cardinal Health, Inc. Release: New Research Proves Clinical Pathways...

Cardinal Health, Inc. Release: New Research Proves Clinical Pathways Can Reduce Cancer Care Costs and Improve Quality While Increasing Physician Reimbursement by 20201, many in the healthcare industry are looking for ways to curb that cost curve while maintaining quality of care for cancer patients and preserving fair compensation for physicians.

Water Analytical Instruments Market in China to Reach Up to USD 550...

The main reasons for growth for analytical instruments in China include flourishing pharmaceutical industry along with the increasing focus towards wastewater treatment.

Immune system cancer drugs tipped to be a $35 bln market

A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year.

Forex shortage cripples Syrian pharmaceutical industry

A shortage of foreign currency has brought Syria's pharmaceutical industry production to a near halt, AFP has reported.

KV reports $3.5 million loss for April

Bridgeton-based KV Pharmaceutical reported a net loss of $3.5 million for the month ended April 30, on revenue of $8.3 million, according to a recent filing with the U.S. Securities and Exchange Commission .

IMPAX Laboratories, Inc. Board Steps in to Oversee Hayward Manufacturing Issues

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! HAYWARD, Calif.

Impax Hires Specialists to Help Sort Manufacturing Issues

Faced with manufacturing quality questions that caused the FDA to reject its potential Parkinson's disease treatment, Impax Laboratories has hired a committee of specialists to oversee quality improvements at its California facility.

Mylan begins drug shipments

Mylan Pharmaceuticals has started shipping fenofibrate tablets in two strengths after receiving final approval from the Food and Drug Administration, the Canonsburg company announced.

Court rules in favor of Mylan in patent case

An appellate court has upheld five patents for Mylan Specialty L.P., reversing a district court's summary judgment affecting the company's Perforomist medication, which is used to treat breathing problems.

Teva Bets on Reformulating Drugs as Investors Say - Show Me'

Teva Pharmaceutical Industries Ltd., which just two years ago was analysts' highest-rated stock among the world's 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy will revive growth.

Pesticide Makers Seek Answers as Bee Losses Sting Agriculture

Monsanto Co is hosting a "Bee Summit." Bayer AG is breaking ground on a "Bee Care Center." And Sygenta AG is funding grants for research into the accelerating demise of honeybees in the United States, where the insects pollinate fruits and vegetables that make up roughly a quarter of the American diet.

Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical...

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of ... (more)

Bristol Myers Squibb And The New Wave Of Cancer Drugs

Even with the best cancer drugs, doctors are forced to switch from one therapy to the next as the tumors rapidly develop resistance.

DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal

The generic drug maker Actavis agreed on Monday to buy Warner Chilcott , a smaller rival, for about $5 billion in stock, in the latest flurry of deal-making in the specialty drug industry.

Chinese pharma companies look West

Zhejiang Hisun Pharmaceutical Co's pavilion at a fair in Beijing. By setting up a joint venture with US-based Pfizer Inc in September, Hisun made a breakthrough in China's pharmaceutical industry by taking a controlling stake in the JV with Pfizer, the world's largest drug-maker by sales.

Breakup of physician, drug company relationship could improve health care, cut cost

A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, more costly and often unnecessary prescription drugs.

Ireland Welcomes Watson Pharmaceuticals, an American Success

Watson Pharmaceuticals , founded by a Taiwanese immigrant in the early 1980s and now a rival to generic drug giants Teva Pharmaceuticals On Monday, Watson capped its intercontinental move when the company announced a $8.5 billion deal to buy Dublin-based- Warner Chilcott .

Strategic Move To Strengthen Consumer Care Business: Bayer To Acquire ...

Bayer signed an agreement Thursday to acquire 100% of the shares of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, a privately held pharmaceutical company specializing in pharmacy-only herbal medicines.

Heard Off the Street: More companies are listening to shareholder concerns over executive pay

Shareholder votes on executive pay mandated by the sweeping Dodd-Frank financial markets overhaul legislation enacted in 2010 are changing how public companies compensate their top executives.

The Fortunate 50: Top execs in region averaged $6.7 million in 2012

Mylan's Robert J. Coury is the highest-paid executive at public companies based in the Tri-State region for the third year in a row, easily outdistancing PPG Industries' Charles E. Bunch, who finished second.

Bristol-Myers Squibb drug study showed effectiveness against advanced melanoma cancer

Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.

Under the Microscope

A little-known federal program widely used in Memphis to provide hospitals and health centers that treat the nation's most vulnerable patients with hefty discounts on outpatient drugs is under scrutiny from Congress, regulators and the pharmaceutical industry.

Delaware's Unclaimed Property Racket:: John Gotti would be proud

Who would have guessed that the State of Delaware's third largest revenue source would essentially be a mafia-like combination of extortion and theft? That's certainly how it sounds when you read Douglas Lindholm's article in Forbes magazine entitled "Once A Friendly Locale To Business, The Modern State Of Delaware Is A Bully." Under the guise of ... (more)

Multivariate Approaches for Powder Characterization

Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.

ILC Dover Receives ISO Class 7 Cleanroom Certification

ILC Dover, the designer and manufacturer of NASA's space suits and a wide range of engineered film and fabric products, announced recently it has received certification for its ISO Class 7 Clean Room.

UK Animal Research Labelling Plan Must Not Put Patients Off Treatment, Says ABPI

New UK proposals to label all drugs as "produced as a result of research on animals" have met with muted response from pharmaceutical industry group, the ABPI.

How Drug Companies Keep Medicine Out of Reach

The promise of delinking research and development from the actual manufacture of drugs, and why the pharmaceutical industry rejects an idea that could turn neglected diseases into profit For almost a decade, the United States has been standing in the way of an idea that could lead to cures for some of the world's most devastating illnesses.

Patheon to Feature its Complex Formulation Technologies Expertise

Patheon Inc ., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, will feature its wide range of complex formulation technologies for small molecules and biologics at the upcoming CPhI/ICSE conference in Tokyo, Japan.

PharMerica to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

The Company also announced that a live broadcast of its conference presentation, as well as any written materials accompanying the presentation, will be available on the "For Investors" tab of the Company's website, www.pharmerica.com , under "Webcasts and Presentations." In addition, the webcast, transcript and written materials will be archived ... (more)

Bristol-Myers Squibb: The Caped Crusaders

Bristol-Myers Squibb's Joseph Campisi and Demetrios Kyonieus were virtually inseparable for eight months in 2012 while they negotiated an M&A deal that was large and complex.

Bristol-Myers Squibb to Present at UBS Global Health Care Conference

Bristol-Myers Squibb Company will present at the UBS Global Health Care Conference on Tuesday, May 21, 2013, in New York City.

Report: Mylan offered $15B for generic drugmaker

Mylan Inc. reportedly has made an unsuccessful $15 billion offer for generic drug manufacturer Actavis.

View Press Release

Research and Markets: PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry A growing emphasis on academic and non-profit organisation partnerships could rescue the pharmaceutical industry from the redundancy of an inefficient R&D model and ... (more)